DOLK variants have also been reported in patients showing a phenotype which overlaps CDG and dystroglycanopathy (DGpathy), with defective N-glycosylation and reduced O-mannosylation [28]. This evidence concerns the gene DOLK and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.